Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioSante expects to support drug study program with $23.8 million from direct stock offering
BioSante expects to support drug study program with $23.8 million from direct stock offering
BioSante expects to support drug study program with $23.8 million from direct stock offering
Submitted by
admin
on March 4, 2011 - 1:00pm
Source:
Yahoo/AP
News Tags:
BioSante
stock offering
Pfizer
Headline:
BioSante expects to support drug study program with $23.8 million from direct stock offering
Do Not Allow Advertisers to Use My Personal information
